CMAB is equipped with a drug product facility with aseptic filling and lyophilizer (GEA) within an open Restricted Access Barrier System (oRABS). All processes are cGMP compliant and are validated to meet customer and regulatory requirements. CMAB’s dedication to quality and optimal services is visible in everything we do.
Lyophilized product design
Thermal characterization of product
Finished product analysis specific to lyophilized products
Karl Fisher moisture
Lyophilized formulation development support
Manufacturing of small-scale batches for development stability
Troubleshooting commercial processes